Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio (2019 - 2026)

Mirum Pharmaceuticals' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 29.52 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 25450.14% year-over-year to 29.52 in Q1 2026; TTM through Mar 2026 was 29.78, a 5027.61% decrease from a year earlier, with the FY2025 full-year figure at 0.05, up 87.73% from the prior year.
• Interest Coverage Ratio eased to 29.52 in Q1 2026 per MIRM's latest filing, from 0.57 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.02 in Q3 2025 and bottomed at 29.52 in Q1 2026.
• The 5-year median for Interest Coverage Ratio is 0.8 (2023), against an average of 3.62.
• Across the five-year window, Interest Coverage Ratio soared 124.2% in 2025 and sank 25450.14% in 2026, its largest moves.
• Year by year, Interest Coverage Ratio stood at 7.84 in 2022, then soared by 70.89% to 2.28 in 2023, then tumbled by 196.61% to 6.77 in 2024, then surged by 91.63% to 0.57 in 2025, then slumped by 5112.65% to 29.52 in 2026.
• Per Business Quant, the three latest MIRM Interest Coverage Ratio figures stand at 29.52 (Q1 2026), 0.57 (Q4 2025), and 0.02 (Q3 2025).